Literature DB >> 8344303

Primary structure of human milk octa-, dodeca- and tridecasaccharides determined by a combination of 1H-NMR spectroscopy and fast-atom-bombardment mass spectrometry. Evidence for a new core structure, the para-lacto-N-octaose.

S Haeuw-Fievre1, J M Wieruszeski, Y Plancke, J C Michalski, J Montreuil, G Strecker.   

Abstract

Two octasaccharides, two dodecasaccharides and a tridecasaccharide have been isolated from human milk by a combination of paper chromatography, high-performance liquid chromatography and high-performance anion-exchange chromatography. Their structural analysis investigated by 400-MHz 1H- and 13C-NMR spectroscopy and by mass spectrometry led to the following structures. [formula: see text] The two octasaccharides have been previously characterized in human milk; the complete assignment of the 1H and 13C spectra is reported here. One of the dodecasaccharides is a tetrafucosyl derivative with a new core: typeI-(beta 1-3)-typeII-(beta 1-3)-typeII-(beta 1-3)-Gal((beta 1-4)Glc, where typeI = Gal(beta 1-3)GlcNAc and typeII = Gal(beta 1-4)GlcNAc. These oligosaccharides display simultaneously Lewis(b) and Lewis(x) determinants or Lewis(a), Lewis(b) and Lewis(x) determinants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344303     DOI: 10.1111/j.1432-1033.1993.tb18042.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Structural characterization of neutral and acidic oligosaccharides in the milks of strepsirrhine primates: greater galago, aye-aye, Coquerel's sifaka and mongoose lemur.

Authors:  Epi Taufik; Kenji Fukuda; Akitsugu Senda; Tadao Saito; Cathy Williams; Chris Tilden; Regina Eisert; Olav Oftedal; Tadasu Urashima
Journal:  Glycoconj J       Date:  2012-02-04       Impact factor: 2.916

2.  Development of an annotated library of neutral human milk oligosaccharides.

Authors:  Shuai Wu; Nannan Tao; J Bruce German; Rudolf Grimm; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

3.  In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.

Authors:  M Nimtz; E Grabenhorst; U Gambert; J Costa; V Wray; M Morr; J Thiem; H S Conradt
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

4.  Structural characterization by multistage mass spectrometry (MSn) of human milk glycans recognized by human rotaviruses.

Authors:  David J Ashline; Ying Yu; Yi Lasanajak; Xuezheng Song; Liya Hu; Sasirekha Ramani; Venkataram Prasad; Mary K Estes; Richard D Cummings; David F Smith; Vernon N Reinhold
Journal:  Mol Cell Proteomics       Date:  2014-07-21       Impact factor: 5.911

5.  Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides.

Authors:  S Thurl; J Henker; M Siegel; K Tovar; G Sawatzki
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 6.  Oligosaccharides of milk and colostrum in non-human mammals.

Authors:  T Urashima; T Saito; T Nakamura; M Messer
Journal:  Glycoconj J       Date:  2001-05       Impact factor: 2.916

7.  Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure.

Authors:  Jun Wada; Takuro Ando; Masashi Kiyohara; Hisashi Ashida; Motomitsu Kitaoka; Masanori Yamaguchi; Hidehiko Kumagai; Takane Katayama; Kenji Yamamoto
Journal:  Appl Environ Microbiol       Date:  2008-05-09       Impact factor: 4.792

Review 8.  Structures and application of oligosaccharides in human milk.

Authors:  Akira Kobata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 9.  Exo- and endoglycosidases revisited.

Authors:  Akira Kobata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

Review 10.  Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis.

Authors:  Xi Chen
Journal:  Adv Carbohydr Chem Biochem       Date:  2015-11-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.